Cargando…
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994717/ https://www.ncbi.nlm.nih.gov/pubmed/33767200 http://dx.doi.org/10.1038/s41541-021-00313-8 |
_version_ | 1783669812571930624 |
---|---|
author | Zou, Jing Xie, Xuping Fontes-Garfias, Camila R. Swanson, Kena A. Kanevsky, Isis Tompkins, Kristin Cutler, Mark Cooper, David Dormitzer, Philip R. Shi, Pei-Yong |
author_facet | Zou, Jing Xie, Xuping Fontes-Garfias, Camila R. Swanson, Kena A. Kanevsky, Isis Tompkins, Kristin Cutler, Mark Cooper, David Dormitzer, Philip R. Shi, Pei-Yong |
author_sort | Zou, Jing |
collection | PubMed |
description | Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7–2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial. |
format | Online Article Text |
id | pubmed-7994717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79947172021-04-16 The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization Zou, Jing Xie, Xuping Fontes-Garfias, Camila R. Swanson, Kena A. Kanevsky, Isis Tompkins, Kristin Cutler, Mark Cooper, David Dormitzer, Philip R. Shi, Pei-Yong NPJ Vaccines Brief Communication Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7–2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial. Nature Publishing Group UK 2021-03-25 /pmc/articles/PMC7994717/ /pubmed/33767200 http://dx.doi.org/10.1038/s41541-021-00313-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Brief Communication Zou, Jing Xie, Xuping Fontes-Garfias, Camila R. Swanson, Kena A. Kanevsky, Isis Tompkins, Kristin Cutler, Mark Cooper, David Dormitzer, Philip R. Shi, Pei-Yong The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title | The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title_full | The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title_fullStr | The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title_full_unstemmed | The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title_short | The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
title_sort | effect of sars-cov-2 d614g mutation on bnt162b2 vaccine-elicited neutralization |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994717/ https://www.ncbi.nlm.nih.gov/pubmed/33767200 http://dx.doi.org/10.1038/s41541-021-00313-8 |
work_keys_str_mv | AT zoujing theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT xiexuping theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT fontesgarfiascamilar theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT swansonkenaa theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT kanevskyisis theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT tompkinskristin theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT cutlermark theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT cooperdavid theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT dormitzerphilipr theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT shipeiyong theeffectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT zoujing effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT xiexuping effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT fontesgarfiascamilar effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT swansonkenaa effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT kanevskyisis effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT tompkinskristin effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT cutlermark effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT cooperdavid effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT dormitzerphilipr effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization AT shipeiyong effectofsarscov2d614gmutationonbnt162b2vaccineelicitedneutralization |